Trial intelligence / Profile preview

HbA1c Reduction for Back Pain in Prediabetes

NCT06064058Completed

Sponsor
University of Baghdad
Start
Jan 2023
Primary completion
Aug 2023
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by University of Baghdad. Primary endpoint: Hemoglobin A1c at 6 months. Started Jan 2023; status: completed.

Beyond the preview

Go deeper on NCT06064058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06064058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call